Dublin, July 27, 2021 (GLOBE NEWSWIRE) -- The "Vitrification Market Size, Share & Trends Analysis Report by Specimen (Oocytes (Devices, Kits & Consumables), Embryo, Sperm), by End-use (IVF Clinics, Biobanks), by Region, and Segment Forecasts, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.
The global vitrification market size is expected to reach USD 20.3 billion by 2027
The market is expected to expand at a CAGR of 17.7% from 2021 to 2027. Several experiments and investigations have been conducted to prove the efficiency of vitrification over slow freezing, leading to its increased clinical implementation. Currently, most IVF clinics are using this method to freeze the eggs/embryos and deliver a higher success rate to patients, thereby driving the market.
Increasing infertility rates have significantly driven the fertility preservation space. Preserving biospecimens has become a common trend among consumers in order to avoid the subsequent consequences of delayed childbearing.
Furthermore, increasing awareness of reproductive health has driven the attention of people towards the freezing of biospecimens. This has created commercial opportunities for players such as Vitrolife and IVF Store that are engaged in offering vitrification solutions for fertility preservation.
The increasing infertility rate is further propelling the demand for products offered in this market. On the other hand, ethical concerns about the preservation of eggs and sperms have hampered the market revenue to a considerable extent. The government and regulatory bodies are working towards addressing the concerns by introducing guidelines on various aspects of fertility preservation space.
Vitrification Market Report Highlights
- Currently, vitrification is primarily preferred for the egg-freezing cycle, due to its high success rate over conventional techniques
- The relatively high upfront cost of embryo freezing, compared to egg freezing, has reduced penetration of this segment as compared to the oocytes segment
- However, with the number of increasing IVF cycles, the oocytes segment is anticipated to be a lucrative option
- On the other hand, although semen preservation has been performed before oocytes preservation, in the fast freezing market, these biospecimens account for a very low share in clinical implementation
- However, a substantial number of researches are being carried out to support the clinical implementation of vitrification under this segment
- Furthermore, the IVF clinics segment dominated the market in 2020 owing to the high usage of rapid cooling devices for oocytes preservation for future IVF procedures
- The biobanks segment is expected to witness considerable growth over the forecast period owing to the increase in the number of individuals seeking fertility preservation services
- Europe is recognized as the leader in Assisted Reproductive Technology (ART) space. This has positively favored the high revenue share of this region in the market in 2020
- Following Europe, North America accounted for the significant revenue share in 2020 owing to the increasing investment in R&D for new vitrification solutions coupled with effective regulatory guidelines to support the fertility preservation arena
- The Asian countries are expected to emerge as the lucrative source of revenue owing to the declining fertility rate in countries coupled with the subsequent increase in demand for vitrification products
- The key companies are engaged in making strategic alliances with other operating players to expand the distribution and market reach of their products
Key Topics Covered:
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Scope & Definitions
1.4 Market Model
1.4.1 Fertility Rate Study, By Country
1.4.2 Market study, by Specimen & Product
1.4.3 Market study, by end use
Chapter 2 Executive Summary
2.1 Market Summary, 2020 (Usd Million)
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Increase in demand due to delayed childbearing/parenthood
3.1.1.2 Social acceptance of fertility preservation techniques
3.1.1.3 Rising awareness about reproductive health
3.1.1.4 Increase in prevalence of infertility and infecundity
3.1.2 Market Restraint Analysis
3.1.2.1 Technical and ethical challenges of fertility preservation
3.1.2.2 Low risk-benefit ratio
3.1.3 Market Opportunity Analysis
3.1.3.1 Advent of automated vitrification equipment
3.2 Penetration and Growth Prospect Mapping for Specimen, 2020
3.3 Pricing Analysis
3.3.1 Conclusion
3.4 Vitrification Market: Company Market Share Analysis, by Region
3.4.1 Company size (2020 Revenue (million))
3.4.2 Geographic Presence
3.4.3 Service/product portfolio
3.4.4 Segment coverage
3.4.5 Marketing strategies
3.4.6 Conclusion
3.5 Business Environment Tools
3.5.1 Vitrification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5.2 Industry Analysis - Porter's
Chapter 4 Specimen Business Analysis
4.1 Vitrification Market: Specimen Movement Analysis
4.2 Oocytes
4.2.1 Global oocytes vitrification market, 2016 - 2027 (USD Million)
4.2.2 Vitrification Devices
4.2.3 Vitrification Kits & Consumables
4.3 Embryo
4.3.1 Global embryo vitrification market, 2016 - 2027 (USD Million)
4.3.2 Vitrification Devices
4.3.3 Vitrification Kits & Consumables
4.4 Sperm
Chapter 5 End-Use Business Analysis
5.1 Vitrification Market: End-use Movement Analysis
5.2 IVF Clinics
5.3 Biobanks
Chapter 6 Vitrification Market: Regional Business Analysis
6.1 Vitrification Market: Regional Movement Analysis
Chapter 7 Company Profiles
- IVF Store
- frozen cell
- vitrolife
- cook medical inc (Cook)
- Minitube
- IMV Technologies
- coopersurgical fertility and genomic solutions
- FUJIFILM IRVINE SCIENTIFIC
- Biotech, Inc. (Cryolock)
- Kitazato Corporation
For more information about this report visit https://www.researchandmarkets.com/r/ntzo16